サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1392398

獣医腫瘍学の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Veterinary Oncology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
獣医腫瘍学の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年11月01日
発行: Value Market Research
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

獣医腫瘍学市場の世界需要は、2022年の3,097億2,000万米ドルから2030年にはほぼ1兆248億2,000万米ドルの市場規模に達すると推定され、調査期間2023～2030年のCAGRは14.22%です。

獣医腫瘍学は、基本的にがんに苦しむペットの診断と治療です。犬や猫は皮膚がんや骨がんなどの病気を発症しやすいです。これらの病気の治療のために安楽死を決定する前に、Hurt Hunger Hydration Hygiene Happiness Mobility Scaleを用いて、ペットの飼い主とQOLについて話し合い、確認します。ペットのがんにつながる要因には、動物の皮膚が常に日光や外部環境にさらされていること、ウイルス、煙、農薬、紫外線、放射性廃棄物などの発がん性物質があります。

市場力学：

リンパ腫、皮膚がん、肥満細胞がんなどのがん疾患の有病率の増加が、獣医腫瘍学市場の高い需要につながっています。ペットの飼育数の増加とペットの健康への関心の高まりが、この市場の需要を急増させています。腫瘍治療薬の安全性と効率性を評価するための動物臨床研究の増加が、同市場の需要を促進しています。さらに、動物ケアセンターに対する民間と政府機関からの資金提供の増加や、ペットの腫瘍学的治療のための研究開発活動の増加が、この市場の需要を押し上げています。さらに、獣医腫瘍学治療における主要製造企業の存在と動物医療支出の増加も、調査期間中の市場成長を後押ししています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、獣医腫瘍学の世界市場における各セグメントを包括的に評価することもできます。獣医腫瘍学業界の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおける獣医腫瘍学市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 獣医腫瘍学-産業分析

  • イントロダクション：市場力学
  • 市場の促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 獣医腫瘍学の世界市場売上分析：治療法別

  • 治療法別概要
  • 実績データと予測データ
  • 治療法別分析
  • 外科療法
  • 放射線療法
  • 化学療法
  • 免疫療法
  • その他

第7章 獣医腫瘍学の世界市場売上分析：動物タイプ別

  • 動物タイプ別概要
  • 実績データと予測データ
  • 動物タイプ別分析
  • イヌ
  • ネコ

第8章 獣医腫瘍学の世界市場売上分析：がんタイプ別

  • がんタイプ別概要
  • 実績データと予測データ
  • がんタイプ別分析
  • リンパ腫
  • 肥満細胞がん
  • 乳腺と扁平上皮がん
  • その他

第9章 獣医腫瘍学の世界市場売上分析：地域別

  • 地域別展望販売分析
  • イントロダクション売上分析
  • 北米売上分析
    • 概要、実績と予測
    • 北米セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第10章 動物用腫瘍薬企業の競合情勢

  • 獣医腫瘍学市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位10社のシェア分析
  • 市場集中度
  • PetCure Oncology
  • Zoetis Inc.
  • Karyopharm Therapeutics Inc.
  • Varian Medical Systems
  • Accuray Incorporated
  • Boehringer Ingelheim GmbH
  • Elanco
  • One Health
  • Regeneus Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Therapy (USD MN)
  • Surgery Market Sales by Geography (USD MN)
  • Radiotherapy Market Sales by Geography (USD MN)
  • Chemotherapy Market Sales by Geography (USD MN)
  • Immunotherapy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Animal Type (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Analysis by Cancer Type (USD MN)
  • Lymphoma Market Sales by Geography (USD MN)
  • Mast Cell Cancer Market Sales by Geography (USD MN)
  • Mammary And Squamous Cell Cancer Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Veterinary Oncology Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Veterinary Oncology Report
  • Market Research Process
  • Market Research Methodology
  • Global Veterinary Oncology Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by Animal Type
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Therapy (USD MN)
  • Surgery Market Sales by Geography (USD MN)
  • Radiotherapy Market Sales by Geography (USD MN)
  • Chemotherapy Market Sales by Geography (USD MN)
  • Immunotherapy Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Animal Type (USD MN)
  • Canine Market Sales by Geography (USD MN)
  • Feline Market Sales by Geography (USD MN)
  • Global Market Analysis by Cancer Type (USD MN)
  • Lymphoma Market Sales by Geography (USD MN)
  • Mast Cell Cancer Market Sales by Geography (USD MN)
  • Mammary And Squamous Cell Cancer Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218350

The global demand for Veterinary Oncology Market is presumed to reach the market size of nearly USD 1024.82 BN by 2030 from USD 309.72 BN in 2022 with a CAGR of 14.22% under the study period 2023 - 2030.

Veterinary oncology is basically the diagnosis and treatment of pets suffering from cancer. Dogs and cats are more prone to develop diseases like skin cancer and bone cancer. It uses the Hurt Hunger Hydration Hygiene Happiness Mobility Scale to discuss and identify their quality of life with pet owners before making a euthanasia decision for the treatment of these diseases. Factors that lead to cancer in pets include constant exposure of animal skin to the sun and external environment, viruses, and carcinogens such as smoke, pesticides, UV light and radioactive waste.

MARKET DYNAMICS:

The increase in the prevalence of cancer diseases such as lymphoma, skin cancer, mast cell cancer etc. is leading to high demand for the veterinary oncology market. Rising pet adoption and a growing focus on pet health are surging the demand for this market. An increase in the number of veterinary clinical studies for evaluating the safety and efficiency of oncology drugs is fostering the demand for this market. In addition, an increase in funding from private & government organizations for animal care centres and a rise in R&D activities for oncology treatment in pets are boosting the demand for this market. Moreover, the presence of key manufacturing companies in veterinary oncology treatment and rise in animal healthcare expenditure is also propelling the market growth during the study.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary oncology. The growth and trends of veterinary oncology industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the veterinary oncology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

  • Surgery
  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • Others

By Animal Type

  • Canine
  • Feline

By Cancer Type

  • Lymphoma
  • Mast Cell Cancer
  • Mammary And Squamous Cell Cancer
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Oncology market include PetCure Oncology, Zoetis Inc., Karyopharm Therapeutics, Inc., Varian Medical Systems, Accuray Incorporated, Boehringer Ingelheim GmbH, Elanco, One Health, Regeneus Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . VETERINARY ONCOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapy
    • 3.7.2 Market Attractiveness Analysis By Animal Type
    • 3.7.3 Market Attractiveness Analysis By Cancer Type
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY THERAPY

  • 6.1 Overview by Therapy
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Therapy
  • 6.4 Surgery Historic and Forecast Sales by Regions
  • 6.5 Radiotherapy Historic and Forecast Sales by Regions
  • 6.6 Chemotherapy Historic and Forecast Sales by Regions
  • 6.7 Immunotherapy Historic and Forecast Sales by Regions
  • 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY ANIMAL TYPE

  • 7.1 Overview by Animal Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Animal Type
  • 7.4 Canine Historic and Forecast Sales by Regions
  • 7.5 Feline Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY CANCER TYPE

  • 8.1 Overview by Cancer Type
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Cancer Type
  • 8.4 Lymphoma Historic and Forecast Sales by Regions
  • 8.5 Mast Cell Cancer Historic and Forecast Sales by Regions
  • 8.6 Mammary And Squamous Cell Cancer Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE VETERINARY ONCOLOGY COMPANIES

  • 10.1. Veterinary Oncology Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF VETERINARY ONCOLOGY INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. PetCure Oncology
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Zoetis Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Karyopharm Therapeutics Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Varian Medical Systems
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Accuray Incorporated
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Boehringer Ingelheim GmbH
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Elanco
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. One Health
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Regeneus Ltd
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies